Sunshine Nationwide: Fed Disclosure Law Meets Some, Not All, Industry Goals
This article was originally published in The Gray Sheet
Executive SummaryDevice industry representatives say they are happy that the new federal mandate for publicly disclosing payments to physicians includes some pre-emptive authority over states, but they hope to convince lawmakers to strengthen that authority before the new rules take effect
You may also be interested in...
The trade group, under its new board chairman José Almeida, plans to push for the relatively new U.S. unique device identifier and Sunshine Act regulations to be the basis of globally harmonized mandates.
Two-and-a-half months late and with only a draft version of the regulations released, CMS is giving device and drug companies, and GPOs, more time to prepare for impending requirements to report physician payments and investment interests to the government for public posting.